Literature DB >> 18684517

MuSK-antibody positive myasthenia gravis: questions from the clinic.

Donald B Sanders1, Vern C Juel.   

Abstract

Clinical vignettes are presented of five patients with MuSK-antibody positive myasthenia gravis, each of which demonstrates a diagnostic or therapeutic issue that is unique to or characteristic of this condition. Consideration of these issues leads to questions, many of which are unanswered at this time, about the immunopathology and management of this subset of myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684517     DOI: 10.1016/j.jneuroim.2008.05.032

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Authors:  Alexandra Pevzner; Benedikt Schoser; Katja Peters; Nicoleta-Carmen Cosma; Andromachi Karakatsani; Berthold Schalke; Arthur Melms; Stephan Kröger
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

Review 2.  Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.

Authors:  Sanjeev Rajakulendran; Stuart Viegas; Jennifer Spillane; Robin S Howard
Journal:  J Neurol       Date:  2012-09-07       Impact factor: 4.849

3.  Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report.

Authors:  Gabriele Monte; Amelia Evoli; Donald B Sanders; Anna Modoni
Journal:  Neurol Sci       Date:  2022-04-19       Impact factor: 3.830

Review 4.  Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

Review 5.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

6.  Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.

Authors:  Anna Kostera-Pruszczyk; Hubert Kwiecinski
Journal:  J Neurol       Date:  2009-06-23       Impact factor: 4.849

7.  Treatment of MuSK-Associated Myasthenia Gravis.

Authors:  Khalid El-Salem; Ahmed Yassin; Kefah Al-Hayk; Salma Yahya; Duha Al-Shorafat; Said S Dahbour
Journal:  Curr Treat Options Neurol       Date:  2014-04       Impact factor: 3.972

Review 8.  Muscle-Specific Kinase Myasthenia Gravis.

Authors:  Lucia S Borges; David P Richman
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

9.  Myasthenia Gravis: Do the Subtypes Matter?

Authors:  J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2020-01-21       Impact factor: 1.383

Review 10.  Complicating autoimmune diseases in myasthenia gravis: a review.

Authors:  Aliona Nacu; Jintana Bunpan Andersen; Vitalie Lisnic; Jone Furlund Owe; Nils Erik Gilhus
Journal:  Autoimmunity       Date:  2015-04-27       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.